Itacitinib

Near Add Your Location

Sorting 1 by

Accepting patients

Itacitinib

Phase 1a/1b Study of Itacitinib (INCB039110) for Cytokine Release Syndrome Prevention and Minimization of Immunosuppression Following Nonmyeloablative Related Partially HLA-mismatched Peripheral Blood Stem Cell Transplant (PBSCT) With High-dose Posttransplantation Cyclophosphamide in Older Patients (Age 60 Years)
  • Allogeneic Stem Cell Transplant
  • JAK1 Inhibitor
  • Phase 1